Acute bronchitis is almost always caused by a virus, and there is no simple way to tell at the bedside whether bacteria are involved. Bacterial infection accounts for fewer than one percent of acute bronchitis cases, which means the odds are overwhelmingly in favor of a viral cause. Yet the question persists because the symptoms feel severe enough that many people assume they need antibiotics, and many clinicians prescribe them anyway. The real challenge is not sorting viral from bacterial bronchitis so much as recognizing the rare situations where bacteria actually matter.
The Odds Are Heavily Stacked Toward a Virus
When researchers have looked at what causes acute bronchitis in otherwise healthy people, the same answer keeps coming back: viruses dominate. Influenza, parainfluenza, rhinoviruses, respiratory syncytial virus, adenoviruses, and coronaviruses are the usual culprits. Bacteria, by contrast, are rarely the primary cause. One review put it bluntly: acute bronchitis is almost always viral in origin, with bacterial infection accounting for fewer than one percent of cases, making antibiotics of no benefit in routine treatment.1PubMed Central. Acute bronchitis
The picture shifts somewhat for people with chronic lung conditions. Among patients experiencing flare-ups of chronic bronchitis, bacteria can be found in the lower airways in roughly half of episodes, and respiratory viruses show up in about 30 percent, sometimes alongside bacteria.2PubMed. Infectious etiology of acute exacerbations of chronic bronchitis But for someone without underlying lung disease who develops a cough after a cold, the cause is almost certainly a virus.
Green or Yellow Mucus Does Not Mean Bacteria
This is one of the most persistent myths in respiratory medicine: if your phlegm turns green or yellow, you must have a bacterial infection and need antibiotics. It sounds logical, and plenty of patients have been handed prescriptions based on exactly this reasoning. But it doesn’t hold up to scrutiny.
The color of sputum comes primarily from enzymes released by white blood cells rushing to fight whatever is irritating the airways. Viral infections trigger inflammation and recruit those same white blood cells, producing the same discolored mucus that a bacterial infection would. One clinical review noted that the presence of purulent sputum does not indicate bacterial infection; it results from sloughing of airway lining cells and the presence of white blood cells.1PubMed Central. Acute bronchitis
A study that actually tested sputum samples from patients with acute cough found that while yellow or green sputum correlated somewhat with bacterial infection, the specificity was only about 46 percent. That means more than half of the people with colored sputum did not have a bacterial infection. The researchers concluded that sputum color in patients with acute cough and no chronic lung disease does not justify prescribing antibiotics.3PubMed Central. Sputum colour for diagnosis of a bacterial infection in patients with acute cough So if your doctor tells you that green phlegm alone isn’t a reason for antibiotics, they’re following the evidence.
Symptoms That Should Raise Concern
If most acute bronchitis is viral and sputum color is unreliable, what should actually prompt you to think something more serious is going on? The most important distinction isn’t really viral versus bacterial bronchitis. It’s bronchitis versus pneumonia, because pneumonia is the condition that genuinely requires treatment and can be dangerous if missed.
A study of adults presenting with acute cough illness found that the strongest predictors of pneumonia were vital-sign abnormalities, particularly low oxygen levels, which carried the strongest association with a pneumonia diagnosis. Being over 50 also increased risk. As the number of abnormal vital signs went up, so did the likelihood of pneumonia: roughly 12 percent of patients with one abnormality had pneumonia, climbing to about 69 percent in those with four abnormalities.4PubMed. Vital-sign abnormalities as predictors of pneumonia in adults with acute cough illness
In practical terms, the signs that should push you toward medical attention include:
- High fever: temperatures above 38°C (100.4°F) that persist beyond a few days or spike suddenly after initial improvement
- Shortness of breath: feeling winded with minimal activity or at rest
- Rapid heart rate or rapid breathing: both are associated with more serious lower respiratory infections
- Worsening after improvement: getting better for a few days and then suddenly getting worse can signal a secondary bacterial infection settling in on top of the original virus
None of these individually prove bacterial infection, but they change the clinical picture enough that further evaluation, including a chest X-ray, is warranted.
Blood Tests That Can Help Distinguish the Cause
When clinicians do want objective data to separate viral from bacterial respiratory infections, blood biomarkers are the main tools available. The two most studied are C-reactive protein (CRP), a general marker of inflammation, and procalcitonin (PCT), which tends to rise more specifically in response to bacterial infections.
A large study across multiple sites in Southeast Asia found that CRP performed better than procalcitonin overall for distinguishing bacterial from viral infections, with an area under the curve of 0.83 compared to 0.74. At a CRP threshold of 20 mg/L, sensitivity for detecting bacterial infections was 86 percent and specificity was 67 percent.5PubMed Central. Performance of C-reactive protein and procalcitonin to distinguish viral from bacterial and malarial causes of fever in Southeast Asia Another study focusing specifically on lower respiratory tract infections found that procalcitonin had higher diagnostic accuracy than CRP for those infections, with an area under the curve of 0.88 and strong specificity at the 0.5 ng/mL cutoff. Combining both markers boosted performance further, reaching roughly 92 percent sensitivity and 93 percent specificity.6Medical Forum Monthly. Role of Serum Biomarkers(Procalcitonin and CRP) in differentiating Bacterial VS Viral Lower Respiratory Tract Infections (LRTIS)
In children, the picture is similar but the individual tests are less impressive on their own. One pediatric study found that the diagnostic accuracy of procalcitonin, CRP, and white blood cell count each fell in the modest range individually, but combining all three was more useful clinically.7PubMed Central. Usefulness of procalcitonin (PCT), C-reactive protein (CRP), and white blood cell (WBC) levels in the differential diagnosis of acute bacterial, viral, and mycoplasmal respiratory tract infections in children The takeaway across these studies is that no single blood test cleanly separates viral from bacterial. Combined markers do better, but they’re imperfect tools, and most cases of acute bronchitis don’t warrant drawing blood in the first place.
When a Cough That Won’t Stop Points to Pertussis
There is one bacterial cause of prolonged cough that deserves special attention: pertussis, commonly known as whooping cough. Most people think of pertussis as a childhood illness, but it is surprisingly common in adults, especially those whose immunity from childhood vaccination has waned over the decades.
A study of adults with persistent cough lasting two weeks or more found that about 21 percent met serologic criteria for pertussis infection.8PubMed. Pertussis infection in adults with persistent cough Another study looking at adults with unexplained cough lasting more than three weeks found even higher rates of antibodies against Bordetella pertussis, with about 71 percent of patients testing seropositive.9PubMed. High prevalence of antibody titers against Bordetella pertussis in an adult population with prolonged cough That doesn’t mean all those people had active pertussis at that moment, since antibodies can reflect past exposure, but it underscores how common pertussis contact is in adults.
Pertussis in adults usually doesn’t produce the dramatic “whoop” sound associated with childhood cases. Instead, it tends to cause a dry, relentless cough that can last six weeks or longer, sometimes accompanied by coughing fits that leave you gasping or even vomiting. Mycoplasma pneumoniae is another atypical bacterial pathogen that can cause bronchitis with a prolonged cough. When both pertussis and mycoplasma are present simultaneously, symptoms can drag on even longer and occasionally lead to more serious respiratory complications.10PubMed Central. Acute Bronchitis Caused by Bordetella Pertussis Possibly Co-Infected with Mycoplasma Pneumoniae If your cough has persisted well beyond three weeks without improvement, pertussis is worth discussing with your doctor.
How a Virus Can Open the Door to Bacteria
One reason the viral-versus-bacterial question gets complicated is that sometimes the answer is both. A viral infection can damage the lining of the airways in ways that make it easier for bacteria to move in afterward. This is sometimes called a “secondary bacterial infection,” and it’s the biological basis for the classic pattern of feeling better for a few days and then suddenly getting worse again.
Research on influenza has mapped this process in detail. The virus damages the epithelial cells lining the respiratory tract, disrupts the normal clearance of mucus, and exposes receptors that bacteria can latch onto. The result is increased bacterial colonization in the nasopharynx that can then spread deeper into the lungs.11PubMed Central. Respiratory tract barrier dysfunction in viral-bacterial co-infection cases Inflammation triggered by the virus also alters immune responses in ways that favor bacterial survival, contributing to both the acquisition of bacteria and the severity of the subsequent infection.12PubMed Central. Secondary bacterial infections in influenza virus infection pathogenesis
This process is more relevant to pneumonia than to simple bronchitis, but it explains why doctors pay attention when a patient’s bronchitis symptoms worsen after an initial improvement. That biphasic pattern, where you get sick, get better, and then get sick again with higher fevers or new shortness of breath, is one of the most useful clinical clues that bacteria may have joined the party.
People with Chronic Lung Disease Face Different Odds
Everything discussed so far applies primarily to otherwise healthy people. If you have COPD, chronic bronchitis, or another chronic lung condition, the calculus changes. Bacteria play a much larger role in flare-ups for these patients, and distinguishing viral from bacterial triggers matters more for treatment decisions.
Researchers developed a scoring system specifically for hospitalized COPD patients to help identify bacterial causes of acute flare-ups. The system uses three readily available markers: CRP above 70 mg/L, symptoms lasting more than one day, and a blood neutrophil count above a certain threshold. Individually, none of these markers were useful enough on their own, but combined into a simple score, the system reached an area under the curve of 0.80 for bacterial causes. Patients scoring low on this scale had a substantially reduced likelihood of bacterial infection, while those scoring high had a meaningfully increased probability.13PubMed Central. A Simple Scoring System to Differentiate Bacterial from Viral Infections in Acute Exacerbations of COPD Requiring Hospitalization
For people living with chronic lung conditions, antibiotics are more often genuinely warranted during exacerbations, particularly when sputum becomes more purulent, increases in volume, and is accompanied by increased breathlessness. But even in this population, not every flare-up needs antibiotics, and the scoring tools are designed to reduce unnecessary treatment.
Why So Many People Get Antibiotics They Don’t Need
Given that bacterial infection is so rare in acute bronchitis, you might expect antibiotic prescribing rates to be low. They aren’t. In fact, acute bronchitis has the highest rate of unnecessary antibiotic prescribing among common upper respiratory conditions. A descriptive study of primary care encounters found that antibiotics were unnecessarily prescribed for acute bronchitis about 74 percent of the time.14PubMed Central. Antibiotic Prescribing Practices for Upper Respiratory Tract Infections Among Primary Care Providers: A Descriptive Study That means roughly three out of four people who walk into a clinic with bronchitis leave with an antibiotic prescription they don’t need.
The reasons are a mix of patient expectations, clinical uncertainty, and time pressure. Patients feel miserable and want something to help. Doctors face a small but nonzero risk of missing a genuine bacterial infection and weigh that against the seemingly low cost of writing a prescription. Visit length in primary care often doesn’t allow for the kind of detailed conversation that would explain why antibiotics won’t help. Quality improvement efforts have shown that these rates can be driven down significantly. One health system brought its inappropriate prescribing rate for acute bronchitis down from about 45 percent to about 33 percent through structured interventions.15PubMed Central. Reducing inappropriate antibiotic prescribing for acute uncomplicated bronchitis: a systemwide quality improvement project A virtual primary care model achieved even better results, with an antibiotic avoidance rate of 92 percent for bronchitis visits.16Telehealth and Medicine Today. Reducing Unnecessary Antibiotic Treatment for Acute Bronchitis Using Virtual Primary Care
Unnecessary antibiotics aren’t harmless. Beyond the well-publicized concern about antibiotic resistance at a population level, there are individual risks: allergic reactions, disruption of gut bacteria, Clostridioides difficile infection, and the false reassurance that can delay recognition of a genuinely worsening condition.
The Delayed Prescription Strategy
One approach that has gained traction is the “delayed prescription,” where a clinician writes an antibiotic prescription but asks the patient to wait a set number of days before filling it and to only use it if symptoms are not improving or are getting worse. It’s a compromise that acknowledges the patient’s concern while reducing actual antibiotic consumption.
A Cochrane review of delayed antibiotic prescriptions for respiratory infections found that the approach significantly reduced antibiotic use compared to immediate prescribing, without increasing complication rates. The review concluded that where clinicians are not confident in withholding antibiotics entirely, delayed prescribing is an acceptable compromise that substantially cuts unnecessary use while maintaining patient safety.17PubMed Central. Delayed antibiotic prescriptions for respiratory infections An individual patient data meta-analysis confirmed these findings and added that delayed prescribing probably reduces the number of return visits compared to offering no prescription at all, with only slightly higher satisfaction scores than the no-prescription approach.18PubMed Central. Delayed antibiotic prescribing for respiratory tract infections: individual patient data meta-analysis
If your doctor hands you a prescription and says “fill this in three days if you’re not improving,” that’s not indecisiveness. It’s an evidence-based approach that protects you without contributing to antibiotic overuse.
What About Rapid Testing at the Doctor’s Office
Newer diagnostic technology, particularly multiplex PCR panels that can detect dozens of viral and bacterial pathogens from a single nasal swab, seemed like they might solve the problem. If you could quickly confirm a specific virus, the thinking went, clinicians would feel more confident skipping antibiotics.
The reality has been disappointing so far. A randomized clinical trial testing whether rapid multiplex PCR results would reduce antibiotic prescribing in adults presenting to acute care with respiratory symptoms found that same-day results did not reduce antibiotic consumption or shorten hospital stays.19PubMed Central. Impact of multiplex respiratory virus testing on antimicrobial consumption in adults in acute care: a randomized clinical trial Knowing a virus was present didn’t change how doctors behaved, possibly because a positive viral test doesn’t rule out a concurrent bacterial infection and because prescribing habits are driven by factors beyond diagnostic certainty.
A more recent trial in primary care found a more nuanced result. Overall, rapid point-of-care microbiological testing did not reduce same-day antibiotic prescribing. But in the subgroup of patients where a virus was specifically detected, prescribing dropped significantly, and patients with chronic lung disease also saw reduced prescribing.20JAMA Internal Medicine. Rapid Respiratory Microbiological Point-of-Care Testing and Antibiotic Use in Primary Care: A Randomized Clinical Trial The technology has potential, but changing prescribing behavior turns out to be harder than just providing better information. The tests are also expensive and not widely available outside hospitals and large clinics.
Vaping, Smoking, and Vulnerability to Respiratory Infections
If you vape or smoke, your airways are already starting from a disadvantaged position when a respiratory infection hits. Research on e-cigarette exposure has documented a pattern of impaired lung defenses that includes abnormal mucus composition, reduced barrier function of the airway lining, and weakened ability of immune cells to engulf pathogens. These changes increase the adhesion of certain bacteria and fungi and can boost the virulence of common respiratory pathogens like influenza, Staphylococcus aureus, and Streptococcus pneumoniae.21PubMed Central. E-cigarette exposures, respiratory tract infections, and impaired innate immunity: a narrative review
Nicotine appears to play a specific role in this. Exposure to e-cigarette vapor with nicotine reduces the volume of the thin liquid layer that sits on top of airway cells and increases its viscosity, making it harder for the airways to clear pathogens normally. Traditional cigarette smoke causes similar and arguably worse damage through additional mechanisms including chronic inflammation, ciliary dysfunction, and direct tissue destruction. For people who smoke or vape, a bout of bronchitis may be more likely to drag on, and the threshold for concern about secondary bacterial involvement is reasonably lower. This doesn’t mean every vaper with a cough needs antibiotics, but it does mean the clinical conversation might be different.